Salary Range:CHF122,500.00 - CHF227,500.00 Job Description Summary#LI-Onsite Location: Basel, Switzerland This role is based in Basel, Switzerland. The Oncology Translational Research (OTR) group at Novartis Biomedical Research is seeking a highly accomplished translational scientist who combines exceptional
Work Your Magic with us! Ready to explore, break barriers, and discover more? We know you’ve got big plans – so do we! Our colleagues across the globe love innovating with science and technology to enrich
Salary Range:CHF169,400.00 - CHF314,600.00 Job Description SummaryJoin us in a high-impact leadership role at the forefront of Oncology drug development. As Senior Global Program Safety Team Lead, you will bring clinical insight, strategic thinking, and strong leadership
Salary Range:CHF93,800.00 - CHF174,200.00 Job Description SummaryLocation: Basel - Onsite #LI-Onsite Novartis cannot offer relocation for this role, please apply if this location is accessible to you. About Us: Novartis Biomedical Research (BR) is the innovation
For our Clinical Safety and Pharmacovigilance team in the Research and Development department based in Lausanne we are looking for a: Safety Physician Oncology 100%, Permanent contract, in Lausanne HQ. In this role, you will be responsible
Salary Range:CHF 0.00 - CHF 0.00 Job Description SummaryThe AI Innovation Postdoctoral Fellow will develop cutting-edge machine learning and generative AI methods for treatment effect modeling, patient stratification, and virtual clinical trials using large-scale clinical trial
Head Medical Affairs, Oncology Location: Zug, Switzerland Are you looking for a role where you can drive medical excellence and truly make an impact on patients’ lives? At GSK, we are united by our purpose: to get
At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create,
Company Description About AbbVie AbbVies mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on
By joining Bio-Techne, you’ll join a company with a powerful and positive purpose of enabling cutting-edge research in Life Sciences and Clinical Diagnostics. Bio-Techne, and all of its brands, provides tools for researchers to further treat
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Salary Range:CHF122,500.00 - CHF227,500.00 Job Description SummaryJob Title: Senior Principal Scientist/Principal Scientist I/II, Oncology (RLT) #LI-Onsite Location: Basel, Switzerland Relocation Support: This role is based in Basel, Switzerland. Novartis is unable to offer relocation support: please only
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our
About kaiko.ai Kaiko is building a next-generation agentic clinical AI assistant that helps clinicians reason across patient data, guidelines, and diagnostics. Healthcare decisions are rarely made by a single person or from a single data source. Kaikos assistant
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
About kaiko.ai Kaiko is building a next-generation agentic clinical AI assistant that helps clinicians reason across patient data, guidelines, and diagnostics. Healthcare decisions are rarely made by a single person or from a single data source. kaikos assistant
About kaiko kaiko.ai is building a next-generation agentic clinical AI assistant that helps clinicians reason across patient data, guidelines, and diagnostics. Healthcare decisions are rarely made by a single person or from a single data source. kaiko’s assistant
Are you a senior designer who wants to shape how a complex clinical platform evolves across genomics, oncology, imaging, and real-world data? Join our Platform Design & Innovation team to own cross-cutting design problems across SOPHiA DDM: a